Literature DB >> 26853151

Cognition and impulsivity in adults with attention deficit hyperactivity disorder with and without cocaine and/or crack dependence.

Carmen S Miguel1, Paula A Martins2, Nathalya Moleda3, Margarete Klein4, Tiffany Chaim-Avancini5, Maria A Gobbo4, Tania M Alves4, Maria A Silva4, Mario R Louzã6.   

Abstract

BACKGROUND: Substance use disorder (SUD) is a common comorbidity in adults with attention deficit-hyperactivity disorder (ADHD). However,there have been few studies on cognitive profiles of these patients. Impulsivity is also commonly increased in both disorders. The central aim of this study was to compare cognition and impulsivity in subjects who had ADHD and cocaine dependence (ADHD+COC group) to those with ADHD only (ADHD-noSUD group). We hypothesized that the ADHD+COC group would show more marked cognitive dysfunction and greater impulsivity than their counterparts with ADHD only.
METHODS: A total of 70 adult patients diagnosed with ADHD according to (DSM-IV-TR) criteria were enrolled; 36 with ADHD+COC and 34 with ADHD-noSUD. All study participants were evaluated with a sociodemographic questionnaire; the Mini International Neuropsychiatric Interview; the Adult ADHD Self-Report Scale; the Addiction Severity Index; the Alcohol, Smoking and Substance Involvement Screening Test; the Barratt Impulsiveness Scale; and a comprehensive neurocognitive battery.
RESULTS: Compared to individuals with ADHD-noSUD, ADHD+COC individuals had significantly lower mean IQ and higher motor impulsivity. On average, the ADHD+COC group also performed more poorly on tasks assessing verbal skills, vigilance, implicit learning during decision making, and ADHD-noSUD performed more poorly on selective attention, information processing, and visual search.
CONCLUSIONS: Our results support the integrative theory of ADHD based on the cognitive and affective neuroscience model, and suggests that ADHD-noSUD patients have impairments in cognitive regulation, while ADHD+COC patients have impairments in both cognitive and affective regulation.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Attention Deficit Disorder with Hyperactivity; Cocaine; Cognition; Decision making; Impulsivity

Mesh:

Year:  2016        PMID: 26853151     DOI: 10.1016/j.drugalcdep.2015.12.040

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  4 in total

Review 1.  Impulsivity and Cluster B Personality Disorders.

Authors:  Daniel Turner; Alexandra Sebastian; Oliver Tüscher
Journal:  Curr Psychiatry Rep       Date:  2017-03       Impact factor: 5.285

2.  Attention Deficit Hyperactivity Disorder, Aggression, and Illicit Stimulant Use: Is This Self-Medication?

Authors:  Annie P Odell; Grace L Reynolds; Dennis G Fisher; Loucine M Huckabay; William C Pedersen; Pamela Xandre; Milica Miočević
Journal:  J Nerv Ment Dis       Date:  2017-05       Impact factor: 2.254

3.  Markers for Severity of Problems in Interpersonal Relationships of Crack Cocaine Users from a Brazilian Multicenter Study.

Authors:  Mayra Pacheco Pachado; Juliana Nichterwitz Scherer; Luciano Santos Pinto Guimarães; Lisia von Diemen; Flavio Pechansky; Felix Henrique Paim Kessler; Rosa Maria Martins de Almeida
Journal:  Psychiatr Q       Date:  2018-12

4.  The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study.

Authors:  Christoffer Brynte; Myriam Aeschlimann; Csaba Barta; Alex Hendikus Abraham Begeman; Amanda Bäcker; Cleo Lina Crunelle; Constanza Daigre; Laura De Fuentes-Merillas; Zsolt Demetrovics; Geert Dom; Lara Grau López; Romain Icick; Brian Johnson; Peter Joostens; Máté Kapitány-Fövény; Emily Karsinti; Falk Kiefer; Maija Konstenius; Frances R Levin; Mathias Luderer; Wiebren Markus; Frieda Matthys; Franz Moggi; Raul Felipe Palma-Alvarez; Maria Paraskevopoulou; J Antoni Ramos-Quiroga; Arnt Schellekens; Leila M Soravia; Norman Therribout; Anil Thomas; Geurt van de Glind; Michiel Willem van Kernebeek; Sabine Vollstädt-Klein; Florence Vorspan; Wim van den Brink; Johan Franck
Journal:  BMC Psychiatry       Date:  2022-09-23       Impact factor: 4.144

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.